NRLC Special Report, Part Three of Three By Randall K. O’Bannon, Ph.D., NRL Director of Education and Research Editor’s note. We saw in Part 1 that the latest data does not support the contention that mifepristone is safer than common drugs like Tylenol, penicillin, and Viagra. In Part 2 , we showed why it doesn’t make sense to compare … Read more
By Dave Andrusko On Friday evening, in a much anticipated decision, U.S. District Judge Matthew J. Kacsmaryk ruled that the FDA’s approval of mifepristone, the first of the two drug chemical abortion technique, should be enjoined. He issued a one week temporary stay to allow the government to appeal. Within hours, the Biden administration said it would. On Monday the Justice Department appealed to the 5th circuit. Chemical … Read more
Editor’s note. On January 3rd of this year, the U.S. Food and Drug Administration (FDA) officially published new rules authorizing appropriately certified pharmacies to stock and distribute abortion pills to women with prescriptions from a certified prescriber. Exactly what this means, and how it affects people in states where there are currently legal protections in … Read more
“Mailed mifepristone mendacity” will 100% result in preventable morbidity and mortality in America’s women By Dr. David Gortler The abortion drug Mifepristone (Mifeprex) entered the U.S. market in 2000. For the past two decades, the drug’s official labeling stated some permutation of the following: “Mifeprex…Administration must be under the supervision of a qualified physician” –and– “Mifeprex may be administered … Read more
Part Three: Pushing against remaining legal limits on mifepristone By Dave Andrusko The Biden administration has greatly expanded the conditions under which abortion pills may be prescribed and sold, but abortion advocates clearly wish to take things further. Today, in our final segment, Dr. Randall K. O’Bannon, who has followed the issue of chemical abortion for … Read more